Hong Kong
PRET, developed at the Hong Kong University of Science and Technology, uses in-context learning to recognise 18 cancer types and complete new pathology tasks with a few annotated slides.
Also, Neurophet has raised over $20 million for the development and global expansion of its AI-based brain imaging analysis software suite.
The AI decision-support system, trained on multimodal ophthalmic data, will assist in diagnosis, treatment planning, and disease monitoring and management.
Hong Kong engineers have developed an AI-powered, metamaterial-based ultrasound lens that can visualise cardiac valve structures closely behind the rib cage.
Powered by conversational AI, the tool aims to plug Hong Kong's palliative care workforce gap – with fewer than one specialist per 100,000 people – as advance medical directive legislation takes effect in May 2026.
Also, digital gynaecology clinic Pinky Promise in India has raised $1 million in pre-seed funding.
The microbiome-based test carries US FDA Breakthrough Device status and is designed to rule out low-risk autism cases early with over 95% negative predictive value.
Also, South Korea's Ministry of Health and Welfare has made more patient data available on the My Health Record app.
The unicorn surgical robotics maker will use the funds to further expand into China and overseas while developing new products.
Trained on 500,000 pathology slides, the AI predicts cancer type, treatment response, and survival with over 95% accuracy within minutes.